Economy & Bankingv1 · 1 version
India's Pharmaceutical Sector
India is the world's pharmacy - the third-largest drug maker by volume, the top supplier of generics, and a USD 60 billion market aiming to more than double to USD 130 billion by 2030. Yet the sector leans on an awkward crutch: for many essential active ingredients, 70% or more of imports still arrive from China. The 2025-26 policy story is a two-front push - PLI money to build API capacity at home, and a regulatory clampdown on unsafe drug combinations.
Last updated 14 July 20266 min read
Latest update
India, the USD 60 bn 'pharmacy of the world' (3rd by volume), leans on PLI to cut 70%+ China API dependence; CDSCO halts 35 unapproved FDCs.
Read the full living note — free
The complete note in both exam lenses (UPSC analytical / fact capsule), its full version history, and “what changed since you last read” — plus tonight's quiz.
Open in CA·WikiAI-assisted, human-reviewed · sourced from PIB, RBI & ministries · editorial policy